Penserra Capital Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,725
Closed -$23K 1502
2021
Q3
$23K Buy
4,725
+25
+0.5% +$144 ﹤0.01% 1222
2021
Q2
$30K Buy
4,700
+105
+2% +$734 ﹤0.01% 1096
2021
Q1
$31K Buy
4,595
+340
+8% +$2.87K ﹤0.01% 897
2020
Q4
$43K Buy
4,255
+2,783
+189% +$18K ﹤0.01% 711
2020
Q3
$5K Buy
+1,472
New +$6.99K ﹤0.01% 860
2020
Q2
Sell
-3,050
Closed -$9K 885
2020
Q1
$9K Hold
3,050
﹤0.01% 812
2019
Q4
$15K Buy
+3,050
New +$17.2K ﹤0.01% 811

Other funds holding PGEN

Penserra Capital Management's PGEN Position: Q4 2021 in Review

Penserra Capital Management sold out of Precigen (PGEN) in Q4 2021, closing a stake of 4,725 shares — an estimated $23K sold.

Penserra Capital Management first reported a position in PGEN in Q4 2019 and held it in 7 quarters. The position peaked at $43K in Q4 2020. 168 funds tracked by Wall St. Rank hold PGEN as of Q4 2021.

  • Penserra Capital Management reported no remaining Precigen position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 4,725 Precigen shares in Q4 2021, an estimated $23K.
  • Penserra Capital Management first reported a position in Precigen in Q4 2019 and held it in 7 quarters.
  • Penserra Capital Management's Precigen position peaked at $43K in Q4 2020.
  • 168 funds tracked by Wall St. Rank held Precigen as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.